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1. Introduction 
Malassezia dermatitis is common in dogs, and less common in cats.1,2 Malassezia spp. are 
commensal yeasts that usually colonize the superficial epidermis of the skin and the ears. The 
non-lipid dependend M. pachydermatis and the lipid dependent M. sympodialis, M. globosa, M. 
nana, M. slooffiae, M. restricta and M. furfur are usually found on the skin or mucosae of dogs 
and cats.1-3 Because Malassezia sp. do not invade subcorneally, it is hypothesized that the 
dermatitis results from inflammatory and/or hypersensitivity reactions to yeast enzymatic 
products and antigens.4 Malassezia-specific IgG and IgE seem to be higher in atopic then normal 
dogs pointing toward a possible involvement in the pathogenesis of atopic dermatitis.5,6 This was 
also shown in humans.7  
Predisposing or triggering factors for Malassezia dermatitis development are as follows: increased 
humidity, presence of skin folds, endocrinopathies (hypothyroidism, diabetes mellitus, 
hyperadrenocorticism), increased populations of staphylococci, immunologic alterations 
(allergies, FIV, neoplasia, glucocorticoid therapy), and genetic predisposition (Basset hound, 
West Highland White Terrier, American Cocker Spaniel, and many other dog breeds, short-hair 
cat breeds such as Sphynx and Rex cats).1-3,8-12 
 
2.  Clinical signs 
Predominant skin lesion in dogs are erythema, scaling, greasiness, crusts, in chronic cases also 
lichenification and hyperpigmentation (localized or generalized).2 Sometimes the disease is 
associated with papules and even furunculosis.2 If affected, the claws show red-brown 
discoloration. Predilection site are lips, ear canals, groin, ventral neck, medial thights, perianal 
area, interdigital skin and skin folds.  In addition to skin changes, nearly all patients experience 
pruritus.2 In the cat, Malassezia dermatitis should be on the differential list, in following clinical 
presentations: 
- Otitis externa (often with accumulations of brown/black and waxy material)  
- Chin acne 
- Facial dermatitis  
- Paronychia and/or red-brown discoloration of  the claws  
- Generalized erythematous scaly to waxy dermatitis2,8,11,13,14 
 
3.  Diagnosis 
Main differential diagnoses include allergic dermatitis, contact dermatitis, superficial 
staphylococcal folliculitis, demodicosis, dermatophytosis, scabies, cheyletiellosis, feline acne and 
epitheliotropic lymphoma. Remember that most of the dogs and cats with Malassezia dermatitis 
have concurrent dermatoses or a systemic disease, which should be screened for. 
 
The diagnosis is made by cytological examination using direct impressions with a microscopic 
slide, swab, superficial scraping or cellophane tape strippings (for less accessible areas such as 
interdigitial skin or dry lesions).2 Whichever method is used, the glass slides are usually stained 
with Romanowsky stain (Diff-Quik®). Optionally, the samples (not scotch tape) can be heat 
fixated before staining.15 This may prevent loss of some material and consequently important 
information during the staining procedure. If one is searching only infectious agents such as 
bacteria and Malassezia just the basophilic stainining component may be used. Additional 
utilization of the eosinophilic stain reveals important information about the inflammatory 
response (Example eosinophils). The yeasts are best visualized at 40x or 100x magnification and 
are round to oval shaped with or without budding (classical “peanut shape”). The yeast diameter 
maybe from 3-8 um in diameter.2 There is no definite yeast number to diagnose Malassezia 
dermatitis. Therefore, the diagnostic criteria for Malassezia dermatitis should always be 
interpreted in the clinical context. Some cases even require a therapeutical trial, to confirm the 
diagnosis. The fungal culture is of no diagnostic value in superficial infections, as dogs and cats 
can be healthy carriers. Important is to have typical clinical lesions with associated Malassezia 
organisms found on the cytological examination. 
 
4.  Treatment 
Treatment options depend on the severity of lesions and the compliance of the owner/patient. 
Small focal areas can be treated with antifungal creams, wipes or ear drops. In multifocal or even 
generalized disease the topical therapy includes application of shampoos and rinses in mono- or 
combined preparations: chlorhexidin, ketoconazole, miconazole, climbazole, selenium sulfide, 
enilconazole, lime sulfur, acetid and boric acid. When topical therapy is impractical or ineffective, 
oral antifugal treatment may be instituted. The most commonly used drugs are itraconazole, 
ketoconazole, terbinafine. 13,16-21 As the therapeutic levels of systemic antifungals persist in the 
skin for several days or weeks, pulse regimens are possible. Newer treatment modalities, such as 
killer peptides, are being described recently.22 Very important is to consider possible drug 
interactions when creating a multimodal therapeutic regimen (example allergic dogs treated with 
cyclosporine). As infections with Malassezia sp. often co-exist with staphylococcal infections, do 
not forget to diagnose and treat also these. Patients with a clinically relevant inflammatory 
component (usually allergic dogs), require additional anti-inflammatory drugs, such as 
glucocorticoids. Antifungal susceptibility testing is not routinely performed, but should be 
considered in refractory cases, as azole-resistant cases have been already encountered in 
veterinary medicine.23 
Dramatic clinical improvement is seen within 1 to 2 weeks (faster if topical and systemic 
medications are combined). The duration of the therapy depends on the resolution of clinical signs 
and should be continued 7-10 days beyond clinical cure, in average altogether 4 weeks.2 
Recurrent cases of Malassezia dermatitis are not unusual, as generally an underlying chronic 
disease is present. Frequent recurrences may require a maintenance protocol with utilization of 
either regular topical (once to twice weekly) or systemic antifungals (1-3 days/week pulses).  
Again, to achieve a good clinical response to treatment, all efforts should be made to 
identify and correct the predisposing factors (allergy, hormonal disturbances, neoplasia, immune-
deficiencies, etc). 
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